Related Experiment Video
Updated: Aug 21, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
[Chronic hepatitis C in HIV co-infected patients. Study of 55 cases with liver biopsy]
Manuel Rubio Caballero1, Carmen Rubio Rivas, Ramón Egido García
1Servicio de Medicina Interna, Hospital Universitario Arnau de Vilanova, Lleida, Spain. mrubio@arnau.scs.es
Insights
Male sex and poor immune status (low CD4+ cell counts) worsen chronic hepatitis C progression in HIV-HCV co-infected patients. These factors are key indicators for monitoring liver disease in this population.
Area of Science:
- Hepatology
- Infectious Diseases
- Immunology
Context:
- HIV-HCV co-infection presents complex challenges in managing chronic liver disease.
- Intravenous drug use is a common risk factor for HCV infection and a significant consideration in HIV co-infection management.
Purpose:
- To investigate the progression of chronic hepatitis C in patients co-infected with HIV.
- To identify clinical and laboratory factors that influence the course of liver disease in this specific patient group.
Summary:
- A study of 55 HIV-HCV co-infected individuals revealed significant correlations between liver disease progression and male gender, lower CD4+ lymphocyte counts, and higher viral loads.
- Multivariate analysis identified male sex and compromised immune status as predictors of poorer outcomes in chronic hepatitis C.
Impact:
- Findings highlight the importance of considering sex and immune status in assessing the risk of liver disease progression in HIV-HCV co-infected patients.
- This research can inform clinical monitoring and therapeutic strategies aimed at mitigating liver damage in individuals with dual infections.
Background And Objective:
To study the evolution of chronic hepatitis in HIV-HCV co-infected patients and the factors conditioning this evolution.
Patients And Method:
55 intravenous drug users with HIV-HCV co-infection were studied. We performed a clinical and laboratory study determining the age at the time of HCV infection and the date of liver biopsy, HIV stage, CD4 cell count, viral load, and time under antiretroviral treatment. Moreover, we analyzed the HCV genotype, HCV viral load, ALT plasmatic level, and liver biopsy. Univariate and multivariate analyses were made.
Results:
55 patients with HIV-HCV co-infection were evaluated. In the multivariate analysis, gender (p = 0.034; 95% confidence interval [CI], 1.306-1082.625), lowest level of CD4+ lymphocytes (p = 0.021; 95% CI, 1,693-653,484) and highest viral load value (p = 0.022; 95% CI, 1366-53,817) were significantly correlated with liver disease progression.
Conclusions:
Both a male sex and a poor immune system situation are associated with a worse evolution of chronic hepatitis C.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
